In addition, we analyzed how an early FDG PET/CT, alone or combined with the pre-treatment HER2 PET/CT, can identify tumor lesions that will not respond (anatomically and metabolically) after three T-DM1 cycles. The gene discussed is ERBB2; the disease is neoplasm.